# A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)

> **NCT03111511** · PHASE1 · COMPLETED · sponsor: **Janssen Sciences Ireland UC** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Drospirenone/Ethinylestradiol
- **DRUG:** Midazolam
- **DRUG:** JNJ-56136379

## Key facts

- **NCT ID:** NCT03111511
- **Lead sponsor:** Janssen Sciences Ireland UC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2017-08-23
- **Final completion:** 2017-08-23
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03111511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03111511, "A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03111511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*